4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline, 98.0%, 250mg

(3a'R,4'S,6'R,7'R,7a'S)-4'-((R)-1,4-Dioxaspiro[4.5]decan-2-yl)tetrahydro-4'H-spiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-c]pyran]-6',7'-diol, 98%, 5g

Ditizone, minimo 85%, pa, ACS, 5 g, confezione in vetro

3-ETHYNYL-1,1-DIFLUOROCYCLOBUTANE, 95.0%, 5g

2-Amino-6-bromophenol, 95.0%, 1g

(1-(2-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)ETHYL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 100mg

N-(2,5-Diethoxyphenyl)-4-methylbenzenesulfonamide, 95%, 500mg

4-Bromonaphthalen-2-amine, 95.0%, 25g

[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl](methyl)amine hydrochloride, 95.0%, 10g

Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 95.0%, 1g

1-(4-Chlorophenyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 250mg

N-Phenylbenzamide, 95.0%, 1kg

TAFLUPROST, 95%, 50mg